Elicio Therapeutics Inc — Dividend History & Yield (NASDAQ:ELTX) | MetaTrader

Open full chart

Financials

Overview 明細書 Statistics Dividends

Quarterly Annual

Dividends per share ———— — Dividend yield % ———— — Payout ratio % ———— —

ニュース

Is Quest Diagnostics (DGX) Stock Outpacing Its Medical Peers This Year?

Elicio Therapeutics (ELTX) Upgraded to Buy: Here's Why

Elicio reports antigen spreading in 87% of evaluated cancer patients

Elicio Therapeutics appoints Marc Wolfgang as chief technology officer

Elicio reports strong immune responses in phase 2 KRAS cancer vaccine trial

Elicio’s cancer therapy shows immune response across diverse HLA types

エリシオのがんワクチンELI-002、患者の99%に強力な免疫反応を示す

Elicio’s cancer vaccine ELI-002 shows strong immune response in 99% of patients

Elicio (ELTX) Q2 Loss Beats Estimates

H.C. Wainwright raises Elicio Therapeutics stock price target to $13 on trial outlook

Elicio Therapeutics to Host Virtual KOL Event on June 25, 2025 to Discuss AMP-Powered ELI-002 for the Treatment of KRAS mutation-driven Pancreatic Cancer

Elicio secures $10 million to extend cash runway